Amid growing pressure from the United States for China to reform its trade policies, the Chinese regime recently announced that it would eliminate tariff duties on all imported cancer drugs, including alkaloid medicines and Chinese herbal medicines.
China’s State Council announced the decision on April 12 and said the changes will be effective beginning May 1.